Evidence map›Paper›PMID 36627840›Full record

ArticleMolecular microbiology2023

The accessory protein TagV is required for full Type VI secretion system activity in Serratia marcescens.

Mark Reglinski, Laura Monlezun, Sarah J Coulthurst

Open access · hybridAbstract read
In one paragraph

Article in Molecular microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mark ReglinskiDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, UK.
Laura MonlezunDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, UK.
Sarah J CoulthurstDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0002-0808-1875
University of Dundee · GB

Funding

Wellcome Trust 097945Wellcome Trust 097945/B/11/ZWellcome Trust 104556Wellcome Trust 104556/Z/14/ZWellcome Trust 220321Wellcome Trust 220321/Z/20/Z
6 · The paper itself

Abstract

The bacterial Type VI secretion system (T6SS) is a dynamic macromolecular structure that promotes inter- and intra-species competition through the delivery of toxic effector proteins into neighbouring cells. The T6SS contains 14 well-characterised core proteins necessary for effector delivery (TssA-M, PAAR). In this study, we have identified a novel accessory component required for optimal T6SS activity in the opportunistic pathogen Serratia marcescens, which we name TagV. Deletion of tagV, which encodes an outer membrane lipoprotein, caused a reduction in the T6SS-dependent antibacterial activity of S. marcescens Db10. Mutants of S. marcescens lacking the core component TssJ, a distinct outer membrane lipoprotein previously considered essential for T6SS firing, retained a modest T6SS activity that could be abolished through deletion of tagV. TagV did not interact with the T6SS membrane complex proteins TssL or TssM, but is proposed to bind to peptidoglycan, indicating that the mechanism by which TagV promotes T6SS firing differs from that of TssJ. Homologues of tagV were identified in several other bacterial genera, suggesting that the accessory function of TagV is not restricted to S. marcescens. Together, our findings support the existence of a second, TssJ-independent mechanism for T6SS firing that is dependent upon the activity of TagV proteins.

Indexed as

Type VI Secretion SystemsBacterial ProteinsMembrane ProteinsSerratia marcescensBacterial ProteinsMembrane ProteinsType VI Secretion Systemsbacterial protein secretionSerratia marcescensType VI accessory genesType VI secretion system

Identifiers

PMID36627840
PMCPMC7614798
OpenAlexW4315619487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.